1. Home
  2. CWT vs IMNM Comparison

CWT vs IMNM Comparison

Compare CWT & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Water Service Group

CWT

California Water Service Group

HOLD

Current Price

$45.12

Market Cap

2.8B

Sector

Utilities

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$22.17

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWT
IMNM
Founded
1926
2006
Country
United States
United States
Employees
1105
N/A
Industry
Water Supply
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CWT
IMNM
Price
$45.12
$22.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$54.50
$32.10
AVG Volume (30 Days)
318.5K
987.9K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
2.97%
N/A
EPS Growth
N/A
7.06
EPS
2.15
N/A
Revenue
$963,695,000.00
$9,041,000.00
Revenue This Year
$9.48
N/A
Revenue Next Year
$3.84
$11.53
P/E Ratio
$20.93
N/A
Revenue Growth
6.41
N/A
52 Week Low
$41.29
$5.15
52 Week High
$51.23
$27.65

Technical Indicators

Market Signals
Indicator
CWT
IMNM
Relative Strength Index (RSI) 49.33 46.03
Support Level $44.20 $18.98
Resistance Level $46.98 $22.57
Average True Range (ATR) 0.96 1.20
MACD -0.10 -0.22
Stochastic Oscillator 40.87 24.19

Price Performance

Historical Comparison
CWT
IMNM

About CWT California Water Service Group

California Water Service Group is a U.S. water and utilities holding company based in California. The company engages in the production, treatment, storage, distribution, and sale of water for various uses. The firm operates through its subsidiaries, which can be divided between regulated and unregulated businesses. The regulated public utilities subsidiaries operate in California, New Mexico, Washington, and Hawaii. The unregulated subsidiaries provide water utility services to private companies and municipalities. The company derives the majority of its revenue from its operations in California and, overall, from residential customers.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: